Fed. Circ. Nixes Injunction On Lupin's Generic Fortamet
The Federal Circuit on Monday lifted an injunction barring Lupin Ltd. from selling its generic version of Shionogi Pharma Inc.'s diabetes drug Fortamet, ruling that questions remain over whether the patent...To view the full article, register now.
Already a subscriber? Click here to view full article